These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9914727)

  • 1. [Effect of somatostatin-octreotide on secretion of adrenocorticotropin, cortisol and neuro-hypophyseal hormones in acromegaly].
    Julesz J; Vecsernyés M; Szász A; Szabados E; Tóth I; Laczi F
    Orv Hetil; 1998 Dec; 139(51):3071-4. PubMed ID: 9914727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a long-acting somatostatin analogue on pituitary-adrenocortical secretion in normal human subjects.
    Itoh S; Tanaka K; Kumage M; Shimizu N
    Endocrinol Jpn; 1990 Feb; 37(1):131-9. PubMed ID: 2166654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome.
    Lanzone A; Fulghesu AM; Guido M; Cucinelli F; Caruso A; Mancuso S
    Fertil Steril; 1997 Jan; 67(1):34-9. PubMed ID: 8986680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
    Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
    J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men.
    Bierwolf C; Burgemeister A; Lüthke K; Born J; Fehm HL
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1151-7. PubMed ID: 9543132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
    Alexander SL; Irvine CH; Livesey JH; Donald RA
    Endocrinology; 1993 Aug; 133(2):860-6. PubMed ID: 8393777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man.
    Rittmaster RS; Cutler GB; Gold PW; Brandon DD; Tomai T; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1987 Feb; 64(2):371-6. PubMed ID: 3025246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interaction of corticotropin releasing factor and arginine vasopressin on adrenocorticotropin and cortisol secretion in Macaca fuscata.
    Hashimoto K; Murakami K; Hattori T; Ota Z
    Acta Med Okayama; 1984 Jun; 38(3):261-7. PubMed ID: 6087620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocorticotropin and cortisol responses to vasopressin during pregnancy.
    Goland RS; Wardlaw SL; MacCarter G; Warren WB; Stark RI
    J Clin Endocrinol Metab; 1991 Aug; 73(2):257-61. PubMed ID: 1649836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone.
    Schlaghecke R; Kornely E; Santen RT; Ridderskamp P
    N Engl J Med; 1992 Jan; 326(4):226-30. PubMed ID: 1309389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of cortisol, vasopressin (AVP), and corticotropin-releasing factor administration on pulsatile adrenocorticotropin, alpha-melanocyte-stimulating hormone, and AVP secretion in the pituitary venous effluent of the horse.
    Livesey JH; Donald RA; Irvine CH; Redekopp C; Alexander SL
    Endocrinology; 1988 Aug; 123(2):713-20. PubMed ID: 2840266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin releasing hormone stimulation test and nocturnal cortisol levels in normal children.
    Dahl RE; Siegel SF; Williamson DE; Lee PA; Perel J; Birmaher B; Ryan ND
    Pediatr Res; 1992 Jul; 32(1):64-8. PubMed ID: 1321974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects.
    Stafford PJ; Kopelman PG; Davidson K; McLoughlin L; White A; Rees LH; Besser GM; Coy DH; Grossman A
    Clin Endocrinol (Oxf); 1989 Jun; 30(6):661-6. PubMed ID: 2574084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels.
    Dimopoulou I; Tsagarakis S; Kouyialis AT; Roussou P; Assithianakis G; Christoforaki M; Ilias I; Sakas DE; Thalassinos N; Roussos C
    Crit Care Med; 2004 Feb; 32(2):404-8. PubMed ID: 14758155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.